NCT04789239: OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosilicate in Heart Failure
- State
- Under way
- Phase
- Phase 2
- People
- 110 planned
- Started
- 1 Sep 2021
- Primary completion
- 31 Dec 2025
- Arms
- SZC + MRA treated heart failure patients
- Results
- None posted
- 9 Mar 2021: Trial registered
- 1 Sep 2021: Trial started